New organotin(IV) derivatives of dipeptides as models for metal-protein interactions: In vitro anti-tumour activity

Applied Organometallic Chemistry

Volumn 17, Issue 5, 2003, Pages 305-314

  Nath, Mala ^a   Pokharia, Sandeep ^a   Song, Xueqing ^b   Eng, George ^b   Gielen, Marcel ^c,d   Kemmer, Martine ^d   Biesemans, Monique ^c   Willem, Rudolph ^c   De Vos, Dick ^e  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

^b UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e TEVA Pharmachemie   (Netherlands)

Author keywords

119Sn M ssbauer; Anti tumour activity; Dipeptides; IR spectroscopy; Multinuclear magnetic resonance; Organotin(IV)

Indexed keywords

ALANINE; AMINO ACID; BUTYLTIN DERIVATIVE; CARBON 13; CARBOXYLIC ACID; CHLORIDE; CISPLATIN; DIPEPTIDE DERIVATIVE; ETOPOSIDE; FLUOROURACIL; GLYCYLTYROSINE; HYDROGEN; LEUCYLLEUCINE; LIGAND; METAL ION; METHOTREXATE; MONOMER; NITROGEN; ORGANOTIN COMPOUND; PEPTIDE; PEPTIDE DERIVATIVE; PHENYL GROUP; SODIUM CHLORIDE; SODIUM GLYCYLLEUCINATE; TIN; TRIPHENYLTIN 4 GLYCYLEUCINATE; TRIPHENYLTIN GLYCYLLEUCINATE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOM; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHEMICAL BOND; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FILTRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED RADIATION; MOLECULAR MODEL; MOSSBAUER SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE;

EID: 0038667821     PISSN: 02682605     EISSN: None     Source Type: Journal    
DOI: 10.1002/aoc.451     Document Type: Article

References (67)

1. Rosenberg B, Van Camp V, Trosko JE, Mansour VH. Nature 1969; 222: 385.
2. Barnard CFJ. Platinum Met. Rev. 1989; 33: 162.
3. Williams DR. Educ. Chem. 1974; 11: 124.
4. Roberts JJ, Pascoe JM. Nature 1972; 235: 282.
5. Crowe AJ, Smith PJ. Chem. Ind. (London) 1980; 200.
6. Clarke MJ, Zhu F, Frasca DR. Chem. Rev. 1999; 99: 2511.
7. Collier WA. Z. Hyg. Infektionskr. 1929; 110: 169.
8. Rose MS. Biochem. J. 1969; 111: 129.
9. Rose MS, Lock EA. Biochem. J. 1970; 120: 151.
10. Farrow BG, Dawson AP. Eur. J. Biochem. 1978; 86: 85.
11. Byrd JT, Andrae MO. Science 1982; 218: 565.
12. Saxena AK, Huber F. Coord. Chem. Rev. 1989; 95: 109 and references cited therein.
13. Barbieri R. Inorg. Chim. Acta 1992; 191: 253.
14. Gupta SP. Chem. Rev. 1994; 94: 1507.
15. Gielen M. Coord. Chem. Rev. 1996; 151: 41.
16. De Vos D, Willem R, Gielen M, van Wingerden KE, Nooter K. Met. Based Drugs 1998; 5: 179.
17. Holloway CE, Melnik M. Main Group Met. Chem. 2000; 23: 1.
18. Holloway CE, Melnik M. Main Group Met. Chem. 2000; 23: 555.
19. Gielen M (ed). Tin-Based Antitumor Drugs, NATO ASI Series, H37. Springer-Verlag: Berlin, 1990.
20. Tiano L, Fedeli D, Moretti M, Falcioni G. Appl. Organometal. Chem. 2001; 15: 575.
21. Gabbianelli R, Villarini M, Falcioni G, Lupidi G. Appl. Organometal. Chem. 2002;; 16: 163.
22. US EPA 738-R-99-010.1999, US EPA, Washington, DC.
23. Crowe AJ, Smith PJ, Cardin CJ, Parge HE, Smith FE. Cancer Lett. 1984; 24: 45.
24. Gielen M, El Khloufi A, Biesemans M, Willem R, Meunier-Piret J. Polyhedron 1992; 11: 1861.
25. Gielen M, Lelieveld P, de Vos D, Pan H, Willem R, Biesemans M, Fiebig HH. Inorg. Chim. Acta 1992; 196: 115.
26. Song X, Yang Z, Xie Q, Li J. J. Organometal. Chem. 1998; 566: 103.
27. Gielen M, Biesemans M, de Vos D, Willem R. J. Inorg. Biochem. 2000; 79: 139.
28. Camacho-Camacho C, de Vos D, Mahieu B, Gielen M, Kemmer M, Biesemans M, Willem R. Main Group Met. Chem. 2000; 23: 433.
29. Kemmer M, Dalil H, Biesemans M, Martins JC, Mahieu B, Horn E, de Vos D, Tiekink ERT, Willem R, Gielen M. J. Organometal. Chem. 2000; 608: 86.
30. Nath M, Yadav R, Gielen M, Dalil H, de Vos D, Eng G. Appl. Organometal. Chem. 1997; 11: 727.
31. Nath M, Pokharia S, Yadav R. Coord. Chem. Rev. 2001; 215: 99 and references cited therein.
32. Barbieri R, Pellerito L, Ruisi G, LoGiudice MT, Huber F, Atassi G. Inorg. Chim. Acta 1982; 66: L39.
33. Ruisi G, Silvestri A, LoGiudice MT, Barbieri R, Atassi G, Huber F, Graetz K, Lamartina L. J. Inorg. Biochem. 1985; 25: 229.
34. Vornefeld M, Huber F, Preut H, Ruisi G, Barbieri R. Appl. Organometal. Chem. 1992; 6: 75.
35. Glowacki BM, Huber F, Preut H, Ruisi G, Barbieri R. Appl. Organometal. Chem. 1992; 6: 83.
36. Girasolo MA, Guli G, Pellerito L, Stocco GC. Appl. Organometal. Chem. 1995; 9: 241.
37. Girasolo MA, Pellerito L, Stocco GC, Valle G. J. Chem. Soc. Dalton Trans. 1996; 1195.
38. Jancso A, Henry B, Rubini P, Vanko G, Gajda T. J. Chem. Soc. Dalton Trans. 2000; 1941.
39. Girasolo MA, Pizzino T, Mansueto C, Valle G, Stocco GC. Appl. Organometal. Chem. 2000; 14: 197.
40. Nath M, Yadav R, Eng G, Nguyen TT, Kumar A. J. Organometal. Chem. 1999; 577: 1.
41. Nath M, Yadav R, Eng G, Musingarimi P. Appl. Organometal. Chem. 1999; 13: 29.
42. Nath M, Yadav R, Eng G, Musingarimi P. J. Chem. Res. 1998; 409.
43. Nath M, Yadav R. Bull. Chem. Soc. Jpn. 1997; 70: 1331.
44. Nath M, Yadav R. Bull. Chem. Soc. Jpn. 1998; 71: 1355.
45. Mason J. Multinuclear NMR. Plenum Press: New York, 1987; 627.
46. Willem R, Bouhdid A, Mahieu B, Ghys L, Biesemans M, Tiekink ERT, de Vos D, Gielen M. J. Organometal. Chem. 1997; 531: 151.
47. Kayser F, Biesemans M, Gielen M, Willem R. In Advanced Applications of NMR to Organometallic Chemistry, Gielen M, Willem R, Wrackmeyer B (eds). John Wiley & Sons: Chichester, 1996; 45-86.
48. Martins JC, Biesemans M, Willem R. Prog. NMR Spectrosc. 2000; 36: 271.
49. Keeler J, Clowes RT, Davis AL, Laue ED. Methods Enzymol. 1994; 239: 145.
50. Willem R, Bouhdid A, Kayser F, Delmotte A, Gielen M, Martins JC, Biesemans M, Mahieu B, Tiekink ERT. Organometallics 1996; 15: 1920.
51. De Vita Jr VT, Hellman S, Rosenberg SA (eds), Cancer: Principles and Practice of Oncology. Lippincott-Raven Publications: Philadelphia, 1997.
52. Keepers YP, Pizao PE, Peters GJ, Van Ark-Otte J, Winigrad B, Pinedo HM. Eur. J. Cancer 1991; 27: 897.
53. Ho BYK, Zuckerman JJ. Inorg. Chem. 1973; 12: 1552.
54. Ford BFE, Liengme BV, Sams JR. J. Organometal. Chem. 1969; 19: 53.
55. Colthup NB, Daly LH, Wiberley SE. Introduction to Infrared and Raman Spectroscopy. Academic Press: New York, 1964; 263.
56. Bellamy LJ. Advances in Infrared Group Frequencies. Methuen: London, 1968; 178, 283.
57. Barbieri R, Pellerito L, Huber F. Inorg. Chim. Acta 1978; 30: L321.
58. Huber F, Haupt HJ, Preut H, Barbieri R, LoGiudice MT. Z. Anorg. Allg. Chem. 1977; 432: 51.
59. Kalinowski HO, Berger S, Braun S. Carbon-13 NMR Spectroscopy. John Wiley & Sons: Chichester, 1988; 221-230.
60. Holecek J, Lycka A. Inorg. Chim. Acta 1986; 118: L15.
61. Gielen M, Dalil H, Ghys L, Boduszek B, Tiekink ERT, Martins JC, Biesemans M, Willem R. Organometallics 1998; 17: 4259.
62. Gielen M, El Khloufi A, Biesemans M, Willem R. Appl. Organometal. Chem. 1993; 7: 119.
63. Gielen M, Bouhdid A, Kayser F, Biesemans M, de Vos D, Mahieu B, Willem R. Appl. Organometal. Chem. 1995; 9: 251.
64. Herber RH, Barbieri R. Gazz. Chim. Ital. 1971; 101: 149.
65. Khoo LE, Charland JP, Gabe EJ, Smith FE. Inorg. Chim. Acta 1987; 128: 139.
66. Bancroft GM, Davies BW, Payne NC, Sham TK. J. Chem. Soc. Dalton Trans. 1975; 973.
67. Davies AG, Smith PJ. In Comprehensive Organometallic Chemistry, Vol. 2. Wilkinson G, Stone FGA, Abel EW (eds). Pergamon Press: Oxford, 1982; 525.